Key facts
- It has raised $43.5M; the latest was Later Stage VC ($10.5M) in Aug 2025.
- Notable investors include Africinvest, Finnish Fund for Industrial Cooperation, Grand Challenges Canada, Soros Economic Development Fund, Open Society Foundations — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Hewatele
- ·The full record, as it builds
Funding rounds
No funding rounds for Hewatele are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hewatele
Supplier of medical oxygen intended to reduce the delay in access to emergency healthcare in remote parts of Africa. The company's services include supplying elements needed in surgical situations, enabling public hospitals, private not-for-profit hospitals, and needy patients to meet their needs at an affordable price.
- Sector
- Healthcare
- HQ
- Nairobi, Kenya
- Founded
- 2014
- Employees
- 20
- Website
- hewatele.org/
- Ownership
- Privately Held (backing)
Hewatele doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hewatele shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hewatele in its N-PORT filings yet. We sweep new filings monthly.